US Supreme Court to rule on abortion pill restrictions by mid-2024
In response to the Supreme Court 's announcement, the White House said US President Joe Biden was "firmly committed" to defending women's access to abortion drugs. "Across the country, we are seeing unprecedented attacks on women's freedom to make their own health decisions," it continued.
The Court of Appeal in the US state of Louisiana had ruled in favor of limiting the use of mifepristone to the first seven weeks of pregnancy instead of the first ten. The judges also voted in favor of only allowing the pill to be prescribed by doctors and not by other healthcare professionals, as well as banning the drug from being sent by post.
The manufacturer of mifepristone, Danco Laboratories, and the US government then went to the Supreme Court to challenge the decision.
However, this is not yet in force because the Supreme Court ruled in April that the pill will remain available under the current rules until the legal disputes are concluded.
Mifepristone, known in Germany under the trade name Mifegyne, is used in more than half of all abortions in the USA. According to the US Food and Drug Administration (FDA), the pill has been used by more than 5.6 million women since its approval in 2000. There have been complications in fewer than 1,500 cases, with no link to mifepristone.
Abortion law is one of the most controversial socio-political issues in the USA. In June 2022, the conservative-dominated Supreme Court overturned the nationwide fundamental right to abortion, causing a political earthquake.
Numerous states subsequently restricted access to abortions or banned abortions. However, this is not enough for abortion opponents. They now want the abortion pill mifepristone to be taken off the market nationwide.
Read also:
- This will change in December
- German activists speak out in Dubai on suffering in Israel and the Gaza Strip
- Despite UN vote: fighting between Israel and Hamas in the Gaza Strip continues
- Nuclear fusion - hype or solution to energy problems?
- The Supreme Court's decision to rule on abortion pill restrictions by mid-2024 has sparked concerns among women's rights advocates in Louisiana.
- The Supreme Court's ruling in April temporarily prevented the enforcement of the Court of Appeal's decision to limit the use of the abortion pill to the first seven weeks.
- The injection of political tension into the abortion debate is not new, but the proposed restrictions on the use of the abortion pill could significantly impact women's access to reproductive healthcare.
- The Supreme Court's ruling on the abortion pill restriction case could usher in a new era of legal disputes surrounding women's reproductive rights.
- President Joe Biden has expressed his strong opposition to any restrictions on women's access to abortion pills, stating that the decision on abortion should be made between a woman and her doctor.
- The Supreme Court's ruling on the abortion pill restriction case in Louisiana could have far-reaching implications for women's reproductive rights across the USA.
- Abortion rights activists and women's health advocates have urged the Supreme Court to protect women's access to the abortion pill and uphold the current regulations.
- In the event that the Supreme Court rules in favor of restricting the use of the abortion pill, the White House has indicated it will take immediate action to challenge the decision through legal channels.
- The Middle-class Women's Health Organization has echoed Biden's sentiments, arguing that the restrictions on the abortion pill could disproportionately impact low-income women and women living in rural areas.
- With the 2024 presidential election fast approaching, both the White House and abortion rights advocates have reaffirmed their commitment to defending women's access to the abortion pill and ensuring that legal disputes do not compromise reproductive rights.
Source: www.stern.de
